Daan Gene Co., Ltd. (SHE:002030)
China flag China · Delayed Price · Currency is CNY
5.06
-0.01 (-0.20%)
Nov 17, 2026, 3:04 PM CST

Daan Gene Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Revenue
776.43757.66853.021,18112,0467,664
Revenue Growth
1.43%-11.18%-27.77%-90.20%57.17%43.49%
Gross Profit
120.3589.3225.35379.788,4315,701
Operating Income
-297.89-541.14-711.11-356.046,0843,901
Net Income
-742.97-744.38-925.17104.665,4123,618
Earnings Per Share
-0.53-0.53-0.660.073.862.58
EPS Growth
----98.19%49.59%47.74%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '24 Jan '24 Jan '23
Financial Business
30.3832.4332.0435.9
Biological Products and Related Business
727.61820.61,14912,010
Offset of Business
-0.32---
Total
757.66853.021,18112,046

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Cash & Investments
1,1941,4881,7942,4003,5612,559
Total Debt
89.53110.48163.94365.83227.8404.06
Net Cash (Debt)
1,1041,3781,6302,0343,3332,155
Net Cash Growth
41.57%-15.46%-19.86%-38.98%54.66%60.03%
Net Cash Per Share
0.790.981.161.362.371.54

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Operating Cash Flow
349.97319.49300.33780.114,1553,305
Capital Expenditures
-109.67-239-174.41-572.77-1,503-658.75
Free Cash Flow
240.3180.49125.92207.342,6522,646
Free Cash Flow Growth
--36.08%-39.27%-92.18%0.24%23.08%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Gross Margin
15.50%11.79%26.42%32.16%69.99%74.39%
Operating Margin
-38.37%-71.42%-83.36%-30.15%50.51%50.90%
Pretax Margin
-94.66%-99.91%-125.57%9.61%52.46%53.76%
Profit Margin
-95.69%-98.25%-108.46%8.86%44.93%47.21%
FCF Margin
30.95%10.62%14.76%17.56%22.02%34.52%

Dividends

Fiscal Year
FY 2023FY 2022FY 2021
Period EndingJan '24 Jan '23 Jan '22
Dividend Per Share
0.0151.7501.110
Dividend Per Share Growth
-99.14%57.66%222.86%
Dividend Yield
0.15%11.25%5.53%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
PE Ratio
---129.814.047.78
Forward PE
-121.50121.50121.50121.50121.50
P/FCF Ratio
29.61103.9263.3165.528.2310.64
PS Ratio
9.1611.049.3511.501.813.67